Asia Pacific Prefilled Syringe Market

The Asia Pacific prefilled syringe market was valued at US$ 1,225.22 million in 2022 and is expected to reach US$ 2,820.57 million by 2030; it is estimated to register a CAGR of 11.0% from 2022 to 2030.

Strategic Initiatives by Market Players Fuel Asia Pacific Prefilled Syringe Market

• In April 2023, Delta Med Group partnered with DBM, a leading manufacturer of prefilled syringes. Delta Med Group and DBM will expand their portfolio, profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity.
• In June 2022, WuXi Biologics launched a drug product facility in China for prefilled syringes. The new facility has PFS capacity of 17 million units per year. The maximum filling speed can reach 400 PFS/min to support the manufacturing of 17 million syringes of drug products every year.
• In January 2022, Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd., received approval for UniSafe 1 ml safety device for prefilled syringes as a combination product in Asia.
• In March 2021, SK bioscience launched a new shingles vaccine called ´SKYZoster® Ini.' The newly introduced prefilled syringe type SKYZoster can be administered more conveniently than the current intramuscular injection type in which water for injection and freeze-dried vaccine are mixed and then transferred back into the syringe.

Thus, a surge in product launches and strategic collaborations is likely to create considerable growth opportunities for the prefilled syringes market in the future.

Asia Pacific Prefilled Syringe Market Overview

The Asia Pacific prefilled syringes market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2022, and India is expected to have a significant growth rate in the market during 2022-2030. The market growth in these countries is attributed to the advancements in treatment of diabetes that have resulted in rising injectable therapies. Moreover, Chinese Diabetes Society has taken a lead in insulin injection education over the past decade for the treatment of diabetes. Therefore, with high awareness and usability of prefilled syringes intended for diabetes population in China, the market for prefilled syringes will grow subsequently in the near future.

Asia Pacific Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Prefilled Syringe Market Segmentation

The Asia Pacific prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the Asia Pacific prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Asia Pacific prefilled syringe market share in 2022.

In terms of material, the Asia Pacific prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Asia Pacific prefilled syringe share in 2022.

Based on designs, the Asia Pacific prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Asia Pacific prefilled syringe share in 2022.

In terms of application, the Asia Pacific prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Asia Pacific prefilled syringe share in 2022.

By distribution channel, the Asia Pacific prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Asia Pacific prefilled syringe market share in 2022.

Based on country, the Asia Pacific prefilled syringe market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific prefilled syringe market in 2022.

B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Asia Pacific prefilled syringe market.

Asia Pacific Prefilled Syringe Strategic Insights

Strategic insights for the Asia Pacific Prefilled Syringe provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Prefilled Syringe Report Scope

Asia Pacific Prefilled Syringe Regional Insights

The geographic scope of the Asia Pacific Prefilled Syringe refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.